Team:Freiburg bioware/Project

From 2009.igem.org

(Difference between revisions)
(Undo revision 144171 by Maximi (Talk))
Line 1: Line 1:
-
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"
+
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
-
dir="ltr" lang="en-US">
+
<html xmlns="http://www.w3.org/1999/xhtml" dir="ltr"
 +
lang="en-US">
<head>
<head>
-
   <meta http-equiv="Content-Type"
+
   <meta content="text/html; charset=UTF-8"
-
content="text/html; charset=UTF-8" />
+
http-equiv="Content-Type" />
-
   <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
+
   <meta content="IE=EmulateIE7" http-equiv="X-UA-Compatible" />
   <title>FREiGEM</title>
   <title>FREiGEM</title>
-
   <script type="text/javascript" src="script.js"></script>
+
   <script src="script.js" type="text/javascript"></script>
-
   <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
+
   <link media="screen" type="text/css" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
-
  type="text/css" media="screen" />
+
  rel="stylesheet" />
-
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
+
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css_ie7&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
</head>
</head>
<body>
<body>
Line 45: Line 46:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a
+
   <li><a class="active"
-
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"
+
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span
-
class="active"><span class="l"></span><span
+
class="l"></span><span class="r"></span><span
-
class="r"></span><span class="t">The
+
class="t">The
Project</span></a>
Project</span></a>
     <ul>
     <ul>
Line 65: Line 66:
  class="t">Human
  class="t">Human
Practice</span></a>
Practice</span></a>
-
      <ul>
+
    <ul>
       <li><a
       <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Ethics">Ethics</a>
  href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Ethics">Ethics</a>
Line 72: Line 73:
  href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</a></li>
  href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</a></li>
     </ul>
     </ul>
-
 
   </li>
   </li>
-
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span class="l"></span><span
+
   <li><a href="#"><span class="l"></span><span
  class="r"></span><span class="t">Notebook</span></a></li>
  class="r"></span><span class="t">Notebook</span></a></li>
   <li><a
   <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
-
  class="t">Parts</span></a><ul>
+
  class="t">Parts</span></a>
 +
    <ul>
       <li><a
       <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic
Line 86: Line 87:
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning">Composite
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning">Composite
Parts</a></li>
Parts</a></li>
-
     </ul></li>
+
     </ul>
 +
  </li>
   <li><a
   <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/Collaboration"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Collaboration"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
  class="t">Collaboration</span></a></li>
  class="t">Collaboration</span></a></li>
-
<li><a
+
  <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
-
  class="t">Modeling</span></a></li>
+
  class="t">Modeling</span></a> </li>
</ul>
</ul>
</div>
</div>
Line 112: Line 114:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
-
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> &nbsp;<img
+
<h2 class="art-PostHeaderIcon-wrapper"> &nbsp;<img
-
style="width: 26px; height: 25px;" alt=""
+
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png"
-
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png" />
+
alt="" style="width: 26px; height: 25px;" />
&nbsp;Project Report<span class="art-PostHeader"></span>
&nbsp;Project Report<span class="art-PostHeader"></span>
</h2>
</h2>
Line 122: Line 124:
</div>
</div>
<div style="text-align: left;">
<div style="text-align: left;">
-
<div style="text-align: justify; left: 15px;"></div>
+
<div style="text-align: justify;"></div>
<table
<table
  style="text-align: left; margin-left: 0px; margin-right: 0px; width: 202px; height: 304px;"
  style="text-align: left; margin-left: 0px; margin-right: 0px; width: 202px; height: 304px;"
Line 139: Line 141:
           <li><a href="#Fok_a">Fok_a</a></li>
           <li><a href="#Fok_a">Fok_a</a></li>
           <li><a href="#Fok_Monomer">Fok-Monomer</a></li>
           <li><a href="#Fok_Monomer">Fok-Monomer</a></li>
-
           <li><a href="#Purification">Purification</a></li>
+
           <li><a href="#Purification">Protein
 +
Expression and Purification</a></li>
           <li><a href="#In_vivo_Expression">In vivo
           <li><a href="#In_vivo_Expression">In vivo
Expression</a></li>
Expression</a></li>
Line 146: Line 149:
           <li><a href="#Cloning_strategy">Cloning
           <li><a href="#Cloning_strategy">Cloning
Strategy</a></li>
Strategy</a></li>
-
           <li><a href="#Expression_">Expression</a></li>
+
           <span style="text-decoration: underline;"></span>
         </ol>
         </ol>
         <li><a href="#Literature_">Literature&nbsp;</a></li>
         <li><a href="#Literature_">Literature&nbsp;</a></li>
Line 176: Line 179:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
-
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> &nbsp;<img
+
<h2 class="art-PostHeaderIcon-wrapper"> &nbsp;<img
-
style="width: 26px; height: 25px;" alt=""
+
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png"
-
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png" />
+
alt="" style="width: 26px; height: 25px;" />
<a name="Summary"></a>Summary<span
<a name="Summary"></a>Summary<span
  class="art-PostHeader"></span> </h2>
  class="art-PostHeader"></span> </h2>
</div>
</div>
<div class="art-PostContent">
<div class="art-PostContent">
-
<div style="text-align: left;">We focused our project on coupling and optimizing the characteristics
+
<div style="text-align: center;"></div>
 +
We focused our project on coupling and optimizing the characteristics
of a restriction endonuclease with short oligonucleotides to develop a
of a restriction endonuclease with short oligonucleotides to develop a
programmable and highly specific enzyme-oligo-complex. As a restriction
programmable and highly specific enzyme-oligo-complex. As a restriction
Line 192: Line 196:
cleavage and restriction domains of FokI and created a novel
cleavage and restriction domains of FokI and created a novel
site-specific endonuclease by linking the cleavage domain to zinc
site-specific endonuclease by linking the cleavage domain to zinc
-
finger proteins.<br>
+
finger proteins.<br />
For our project we generated two Fok heterodimers (Miller, Nature
For our project we generated two Fok heterodimers (Miller, Nature
biotech, 2007). For the catalytic active Fok partner, named Fok_a, the
biotech, 2007). For the catalytic active Fok partner, named Fok_a, the
Line 206: Line 210:
aspartate 450 was switched to alanine (GAC-&gt;GCG) and aspartate
aspartate 450 was switched to alanine (GAC-&gt;GCG) and aspartate
467
467
-
to alanine (GAT-&gt;GCG).<br>
+
to alanine (GAT-&gt;GCG).<br />
-
<br>
+
<br />
 +
<div style="text-align: justify;"></div>
<table
<table
-
  style="text-align: left; width: 509px; height: 378px; float: left;"
+
  style="float: left; text-align: left; margin-top: 2px; margin-right: 20px; margin-bottom: 15px; background-color: rgb(205, 219, 229); width: 263px; height: 237px;"
-
  border="0" cellpadding="0" cellspacing="0">
+
  border="1" cellpadding="2" cellspacing="0">
   <tbody>
   <tbody>
     <tr>
     <tr>
-
       <td><img style="width: 503px; height: 338px;"
+
       <td><img style="width: 300px; height: 202px;"
  alt=""
  alt=""
-
  src="https://static.igem.org/mediawiki/2009/0/04/Freiburg09_Foka_foki_in_action.JPG"></td>
+
  src="https://static.igem.org/mediawiki/2009/0/04/Freiburg09_Foka_foki_in_action.JPG" /></td>
     </tr>
     </tr>
     <tr>
     <tr>
-
       <td style="background-color: rgb(50, 122, 153);">Association
+
       <td><small>Association of linker FluA and Dig with
-
of linker FluA and Dig with DNA and Fok_a and Fok_i monomers</td>
+
DNA and</small> <small>Fok_a
 +
and Fok_i monomers</small></td>
     </tr>
     </tr>
   </tbody>
   </tbody>
</table>
</table>
-
<br>
+
<div style="text-align: justify;">The two heterodimeric
-
The two heterodimeric partners were fused to different anticalins
+
partners were fused to different anticalins
binding different adapter molecules. Thus Fok_i is fused to anticalin
binding different adapter molecules. Thus Fok_i is fused to anticalin
on Fluorescein and Fok_a to anticalin on Digoxigenin. These adapter
on Fluorescein and Fok_a to anticalin on Digoxigenin. These adapter
Line 238: Line 244:
binding protein to test the optimal distance to preserve the most
binding protein to test the optimal distance to preserve the most
possible flexibility and most possible precision of the heterodimeric
possible flexibility and most possible precision of the heterodimeric
-
Foks.
+
Foks.<br />
 +
<br />
 +
<br />
 +
<br />
 +
<br />
 +
<br />
 +
<br />
 +
<br />
 +
<table
 +
style="margin-top: 4px; margin-left: 20px; text-align: left; float: right; background-color: rgb(205, 219, 229); width: 443px; height: 417px;"
 +
border="1" cellpadding="2" cellspacing="0">
 +
  <tbody>
 +
    <tr>
 +
      <td><img style="width: 500px;" alt=""
 +
src="https://static.igem.org/mediawiki/2009/5/5e/Freiburg09_fokmodel_fig4.png" /><br />
 +
      </td>
 +
    </tr>
 +
    <tr>
 +
      <td><small>complete universal restriction enzyme.
 +
Blue: DNA strand; Red: two 16bp
 +
long Oligos,</small> <small>tags as indicated in the
 +
picture. Ochre: Fluorescein A
 +
binding lipocalin; Orange: digoxigenin</small> <small>binding
 +
lipocalin; Yellow:
 +
tagged Base with C6 linkers and attached tags; light Blue: inactive
 +
FokI</small> <small>cleavage domain; Red: FokI active
 +
cleavage domain; Green: three
 +
catalytically active aminoacids; White: two Calcium ions</small></td>
 +
    </tr>
 +
  </tbody>
 +
</table>
 +
<div style="text-align: justify;">The place where all the
 +
cutting events will take place in our scenery
 +
is the thermocycler. Therefore all the ingredients, i.e. chromosomal or
 +
plasmid DNA of interest, modified oligonucleotides and the different
 +
heterodimers Fok_a and Fok_i are mixed together. At high temperatures
 +
the DNA will denaturate allowing the different partners to find each
 +
other, cut the DNA, and fall apart in course of one thermocycle. The
 +
whole procedure can be repeated undefinately. To reach this step, we
 +
need to improve the thermostability of our enzyme via phage display.
 +
Creating a universal restriction enzyme provides not only the
 +
possibility to improve routine cloning but also to enhance therapeutic
 +
gene repair via triplex technology. Many genetic diseases and
 +
especially ones arising from single nucleotide polymorphisms (SNPs) or
 +
monogenetic disease can be alleviated by the replacement of mutated
 +
genes using this method. To cut double stranded DNA the
 +
oligonucleotides have to be replaced by triple helix forming oligos
 +
(TFO). They can bind double-stranded DNA in homopurin- or
 +
homopyrimidine-rich areas. But developments are also made to widen the
 +
possible interaction domains of the DNA and hence make the TFOs as
 +
programmable as our conventional oligonucleotides. In case of the human
 +
genome of 3&times;10^9 bp size, a highly specific artifical
 +
endonuclease
 +
would be necessary to address the mutated gene explicitly. The used
 +
TFOs therefore have to possess a minimum length of 16 bp to cut just
 +
once in the human genome (4^16 bp = 4.3*10^9 bp).<br />
 +
<br />
 +
<div style="text-align: justify;">Additionally, we provide
 +
an alternative way of binding by the coupling
 +
of the cleavage domain to the transcription factor Fos. This concept
 +
also includes the activity regulation by photo-switching. We<br />
 +
are also
 +
modifying an argonaute protein into a DNA endonuclease using phage
 +
display technics.
 +
</div>
 +
</div>
 +
<div style="text-align: left;"></div>
</div>
</div>
<br />
<br />
Line 262: Line 334:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
-
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> &nbsp;<img
+
<h2 class="art-PostHeaderIcon-wrapper"> &nbsp;<img
-
style="width: 26px; height: 25px;" alt=""
+
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png"
-
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png" />
+
alt="" style="width: 26px; height: 25px;" />
&nbsp;<a name="Subprojects"></a>Subprojects<span
&nbsp;<a name="Subprojects"></a>Subprojects<span
  class="art-PostHeader"></span> </h2>
  class="art-PostHeader"></span> </h2>
</div>
</div>
<div class="art-PostContent">
<div class="art-PostContent">
-
<div style="text-align: left;"><a
+
<div style="text-align: center;"></div>
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Modelling">Modelling</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#3D-Modelling">3D-Modelling</a><br>
+
-
<a href="https://2009.igem.org/Team:Freiburg_bioware/Project#Fok_a">Fok_a</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Fok_Monomer">Fok-Monomer</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Purification">Purification</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#In_vivo_Expression">In
+
-
vivo
+
-
Expression</a><br>
+
-
<a href="https://2009.igem.org/Team:Freiburg_bioware/Project#AGO">AGO</a><br>
+
-
<a href="https://2009.igem.org/Team:Freiburg_bioware/Project#FOS">FOS</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Cloning_strategy">Cloning
+
-
Strategy</a><br>
+
-
<a
+
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Expression_">Expression</a>
+
-
</div>
+
<br />
<br />
-
<div style="text-align: center;">
+
<div style="text-align: left;">
</div>
</div>
<br />
<br />
Line 312: Line 364:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
-
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper">&nbsp;<img
+
<h2 class="art-PostHeaderIcon-wrapper">&nbsp;<img
-
style="width: 26px; height: 25px;" alt=""
+
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png"
-
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png" />
+
alt="" style="width: 26px; height: 25px;" />
<a name="Highlights"></a>Highlights<span
<a name="Highlights"></a>Highlights<span
  class="art-PostHeader"></span> </h2>
  class="art-PostHeader"></span> </h2>
Line 320: Line 372:
<div class="art-PostContent">
<div class="art-PostContent">
<div style="text-align: left;"><br />
<div style="text-align: left;"><br />
-
<h4><a name="Modelling"></a>Modelling</h4>
+
<h4><a name="Modelling"></a>Modeling</h4>
<a href="#">Read more...</a>
<a href="#">Read more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
-
<h4><a name="3D-Modelling"></a>3D-Modelling</h4>
+
<h4><a name="3D-Modelling"></a>3D-Modeling</h4>
<a href="#">Read more...</a>
<a href="#">Read more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
Line 331: Line 383:
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
<h4><a name="Fok_Monomer"></a>Fok Monomer</h4>
<h4><a name="Fok_Monomer"></a>Fok Monomer</h4>
-
<a href="#">Read more...</a>
+
<br />
 +
<table style="text-align: left; width: 900px;" border="0"
 +
cellpadding="2" cellspacing="2">
 +
  <tbody>
 +
    <tr>
 +
      <td><img alt=""
 +
src="/wiki/index.php?title=User:Maximi/new_general_style.css&amp;action=raw&amp;ctype=text/css" /><img
 +
style="width: 181px; height: 189px;" alt=""
 +
src="https://static.igem.org/mediawiki/2009/f/fd/Freiburg09_Dummy.jpg" /></td>
 +
      <td>
 +
      <p class="MsoNormal" style="text-align: justify;"><span
 +
style="" lang="EN-GB">In order to create a universal
 +
restriction
 +
enzyme we followed several ideas and models. The first and most
 +
promising idea
 +
we had was to create a Fok Monomer as it represents the optimal and
 +
easiest
 +
model for a universal restriction enzyme<o:p></o:p></span><u><span
 +
style="" lang="EN-GB"><o:p><span
 +
style="text-decoration: none;"></span></o:p></span></u></p>
 +
      <p class="MsoNormal" style="text-align: justify;"><u><span
 +
style="" lang="EN-GB"><o:p><span
 +
style="text-decoration: none;"></span></o:p></span></u><span
 +
style="" lang="EN-GB">If we are able to employ a
 +
monomeric enzyme,
 +
this protein would have a couple of advantages. Most importantly we
 +
would no longer
 +
need two separate oligonucleotides to achieve specific binding and
 +
cutting of
 +
the target DNA. Also only one protein has to be purified &ndash;
 +
thus saving time and
 +
money. A scientific advantage is the option to optimize the monomer by
 +
phage
 +
display. Using this technology, we would have the chance to create a
 +
thermostable, specific, universal restriction enzyme whose DNA binding
 +
activity
 +
is only created by a single oligonucleotide.<o:p></o:p></span><u><span
 +
style="" lang="EN-GB"><o:p><span
 +
style="text-decoration: none;"></span></o:p></span></u></p>
 +
      <p class="MsoNormal" style="text-align: justify;"><u><span
 +
style="" lang="EN-GB"><o:p><span
 +
style="text-decoration: none;"></span></o:p></span></u><span
 +
style="" lang="EN-GB">Our goal was firstly to create
 +
a Fok-monomer which
 +
is able to cut DNA without a primary dimerization step and secondly to
 +
show
 +
that our heterodimeric interface design works properly. To reach this,
 +
we had
 +
to clone all the required parts one after another, resulting in a huge
 +
fusion
 +
protein.<o:p></o:p></span></p>
 +
      </td>
 +
    </tr>
 +
  </tbody>
 +
</table>
 +
<a
 +
href="https://2009.igem.org/Team:Freiburg_bioware/Project/fokmonomer">Read
 +
more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
-
<h4><a name="Purification"></a>Purification</h4>
+
<h4><a name="Purification"></a>Protein
 +
Expression and Purification</h4>
<a href="#">Read more...</a>
<a href="#">Read more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
Line 343: Line 453:
<a href="#">Read more...</a>
<a href="#">Read more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
-
<h4><a name="FOS"></a>FOS</h4>
+
<h4><a name="FOS"></a>Alternative way
-
<a href="#">Read more...</a>
+
of binding: Jun/Fos</h4>
 +
<br />
 +
<table style="text-align: left; width: 900px;" border="0"
 +
cellpadding="2" cellspacing="2">
 +
  <tbody>
 +
    <tr>
 +
      <td><img style="width: 109px; height: 109px;"
 +
alt=""
 +
src="https://static.igem.org/mediawiki/2009/5/57/Freiburg09_1FOS.jpg" /></td>
 +
      <td>We also thought of an alternative way of binding of the
 +
heterodimeric
 +
Fok to the DNA avoiding the necessity of labelled oligos and their
 +
binding proteins using the binding domain of a transcription factor as
 +
a new adapter. We focused on the binding domain of the activator
 +
protein-1 (AP-1) a crucial transcription factor implicated in numerous
 +
cancers. The protein is composed by a series of dimers. Nine homologues
 +
of the AP-1 leucine zipper region have been characterized, among them
 +
c-Fos, c-Jun and semirational library-designed winning peptides FosW
 +
and JunW. Via leucin zipper they interact among each other and with
 +
their basic region they bind DNA.</td>
 +
    </tr>
 +
  </tbody>
 +
</table>
 +
<a href="https://2009.igem.org/Team:Freiburg_bioware/Project/FOS">Read
 +
more...</a>
<hr style="width: 100%; height: 2px;" />
<hr style="width: 100%; height: 2px;" />
<h4><a name="Cloning_strategy"></a>Cloning
<h4><a name="Cloning_strategy"></a>Cloning
strategy</h4>
strategy</h4>
<a href="#">Read more...</a>
<a href="#">Read more...</a>
-
<hr style="width: 100%; height: 2px;" />
+
<hr style="width: 100%; height: 2px;" /></div>
-
<h4><a name="Expression_"></a>Expression</h4>
+
-
<a href="#">Read more...</a>
+
-
 
+
-
</div>
+
-
<br />
+
-
<div style="text-align: center;">
+
-
</div>
+
-
<br />
+
</div>
</div>
<div class="cleared"></div>
<div class="cleared"></div>
Line 376: Line 502:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
-
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"><a
+
<h2 class="art-PostHeaderIcon-wrapper"><a
  name="Literature_"></a> &nbsp;<img
  name="Literature_"></a> &nbsp;<img
-
style="width: 26px; height: 25px;" alt=""
+
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png"
-
  src="https://static.igem.org/mediawiki/2009/6/69/Freiburg09_PostHeader_tanne.png" />
+
alt="" style="width: 26px; height: 25px;" />
Literature<span class="art-PostHeader"></span> </h2>
Literature<span class="art-PostHeader"></span> </h2>
</div>
</div>

Revision as of 18:57, 21 October 2009

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> FREiGEM



We focused our project on coupling and optimizing the characteristics of a restriction endonuclease with short oligonucleotides to develop a programmable and highly specific enzyme-oligo-complex. As a restriction endonuclease we chose the cleavage domain of the well studied endonuclease FokI from Flavobacterium okeanokoites. Normally FokI acts as a homodimer, each dimer divided in cleavage and restriction domain. Chandrasegaran and Miller have already made experiments to uncouple the cleavage and restriction domains of FokI and created a novel site-specific endonuclease by linking the cleavage domain to zinc finger proteins.
For our project we generated two Fok heterodimers (Miller, Nature biotech, 2007). For the catalytic active Fok partner, named Fok_a, the first 1158 nucleotides, i.e. the recognition domain, were deleted and glutamate 490 was switched to lysine (GAA->AAA) as well as isoleucine 538 to lysine (ATC->AAA) for the heterodimer formation. For the catalytic inactive Fok partner, named Fok_i, the heterodimeric amino acids glutamine 486 was switched to glutamate (CAA->GAA) and isoleucine 499 to leucine (ATC->CTG) and the catalytic amino acids aspartate 450 was switched to alanine (GAC->GCG) and aspartate 467 to alanine (GAT->GCG).

Association of linker FluA and Dig with DNA and Fok_a and Fok_i monomers
The two heterodimeric partners were fused to different anticalins binding different adapter molecules. Thus Fok_i is fused to anticalin on Fluorescein and Fok_a to anticalin on Digoxigenin. These adapter molecules are linked to oligonucleotides mediating the binding of the DNA site of interest. Now the heterodimerization comes into play. If the different Fok_i and Fok_a constructs bind their target oligos and come together, the inactive domain will serve simply as an activator of the active domain, cutting only one strand of the DNA. In our 3D models we showed that Fok domains are positioned in such a way that Fok_a will cut the DNA and Fok_i the modified oligonucleotide. Thus the inactivation of Fok_i allows the reuse of our oligonucleotides. Different linkers were designed and fused between cleavage domain and binding protein to test the optimal distance to preserve the most possible flexibility and most possible precision of the heterodimeric Foks.








complete universal restriction enzyme. Blue: DNA strand; Red: two 16bp long Oligos, tags as indicated in the picture. Ochre: Fluorescein A binding lipocalin; Orange: digoxigenin binding lipocalin; Yellow: tagged Base with C6 linkers and attached tags; light Blue: inactive FokI cleavage domain; Red: FokI active cleavage domain; Green: three catalytically active aminoacids; White: two Calcium ions
The place where all the cutting events will take place in our scenery is the thermocycler. Therefore all the ingredients, i.e. chromosomal or plasmid DNA of interest, modified oligonucleotides and the different heterodimers Fok_a and Fok_i are mixed together. At high temperatures the DNA will denaturate allowing the different partners to find each other, cut the DNA, and fall apart in course of one thermocycle. The whole procedure can be repeated undefinately. To reach this step, we need to improve the thermostability of our enzyme via phage display. Creating a universal restriction enzyme provides not only the possibility to improve routine cloning but also to enhance therapeutic gene repair via triplex technology. Many genetic diseases and especially ones arising from single nucleotide polymorphisms (SNPs) or monogenetic disease can be alleviated by the replacement of mutated genes using this method. To cut double stranded DNA the oligonucleotides have to be replaced by triple helix forming oligos (TFO). They can bind double-stranded DNA in homopurin- or homopyrimidine-rich areas. But developments are also made to widen the possible interaction domains of the DNA and hence make the TFOs as programmable as our conventional oligonucleotides. In case of the human genome of 3×10^9 bp size, a highly specific artifical endonuclease would be necessary to address the mutated gene explicitly. The used TFOs therefore have to possess a minimum length of 16 bp to cut just once in the human genome (4^16 bp = 4.3*10^9 bp).

Additionally, we provide an alternative way of binding by the coupling of the cleavage domain to the transcription factor Fos. This concept also includes the activity regulation by photo-switching. We
are also modifying an argonaute protein into a DNA endonuclease using phage display technics.





Modeling

Read more...

3D-Modeling

Read more...

Fok mit Aktivität

Read more...

Fok Monomer


In order to create a universal restriction enzyme we followed several ideas and models. The first and most promising idea we had was to create a Fok Monomer as it represents the optimal and easiest model for a universal restriction enzyme

If we are able to employ a monomeric enzyme, this protein would have a couple of advantages. Most importantly we would no longer need two separate oligonucleotides to achieve specific binding and cutting of the target DNA. Also only one protein has to be purified – thus saving time and money. A scientific advantage is the option to optimize the monomer by phage display. Using this technology, we would have the chance to create a thermostable, specific, universal restriction enzyme whose DNA binding activity is only created by a single oligonucleotide.

Our goal was firstly to create a Fok-monomer which is able to cut DNA without a primary dimerization step and secondly to show that our heterodimeric interface design works properly. To reach this, we had to clone all the required parts one after another, resulting in a huge fusion protein.

Read more...

Protein Expression and Purification

Read more...

In vivo Expression

Read more...

AGO

Read more...

Alternative way of binding: Jun/Fos


We also thought of an alternative way of binding of the heterodimeric Fok to the DNA avoiding the necessity of labelled oligos and their binding proteins using the binding domain of a transcription factor as a new adapter. We focused on the binding domain of the activator protein-1 (AP-1) a crucial transcription factor implicated in numerous cancers. The protein is composed by a series of dimers. Nine homologues of the AP-1 leucine zipper region have been characterized, among them c-Fos, c-Jun and semirational library-designed winning peptides FosW and JunW. Via leucin zipper they interact among each other and with their basic region they bind DNA.
Read more...

Cloning strategy

Read more...